Ivy League researchers discover unusual craving in every woman

Touch her like this to provoke fiery desire

Unsubscribe | Report as spam | Change email preferences

—-Important Message—-

Ivy League researchers have just discovered an unusual sexual “craving” in every woman

Can't see this image? Click on 'load images' or 'always allow images for this sender'

You simply add it to your regular intercourse, foreplay, or quickie…

And it will make her climax so powerfully… she might pull some of your hair out!

Plus, she’s more likely to have an orgasm during vaginal sex…

It’s working like crazy for men of all ages, including 66-year old Michael who used this on his 38-year old smoking hot girlfriend.

Along with the fact that the idea is so hot, it’s kinda like a “fetish” for some men and women.

Add this to any sex routine for a soul-gripping orgasm…

———-

Is this 70 year old treatment a magic cure for pain?

There’s a lot of chatter in some places on the Internet right now about the use of low-dose naltrexone for pain.

If you’ve never heard of this though, don’t worry, you’re not alone.

Most doctors don’t know about low-dose naltrexone, because the FDA has never approved its use for pain.

But the studies that are being done recently on how this treatment can work to combat chronic pain are promising…

So I wanted to make sure I brought it to your attention.

Can't see this image? Click on 'load images' or 'always allow images for this sender'

Naltrexone is an old treatment that was developed in the 1960s and that’s given to people who have alcohol dependence.

When used for this reason, the typical dose is 50 to 100 mg.

When people use naltrexone for pain they usually take much lower doses – typically between 1 to 4.5mg.

People report amazing results, and the studies so far have been promising.

Low-dose naltrexone has been shown to lower neuro-inflammation and keep inflammatory chemicals from being dumped into the body.

Low-dose naltrexone (LDN) has shown promise to reduce symptoms related to chronic pain conditions such as fibromyalgia, inflammatory bowel conditions, and multiple sclerosis. The mechanism of LDN appears to be modulation of neuro-inflammation, specifically, the modulation of the glial cells and release of inflammatory chemicals in the central nervous system. These effects appear to be unique at low dosage compared to dosage for ‘FDA’ approved use for alcohol and opioid dependence.

Even in very difficult to treat diseases like fibromyalgia, low-dose naltrexone is often quite effective.

Two small prospective pilot studies have previously shown that treatment with low-dose naltrexone may be an effective, safe, and inexpensive treatment for fibromyalgia.

The studies that have been done so far on low-dose naltrexone do have limitations.

They are mostly smaller studies and don’t have a good double blind set up.

Despite initial promise of efficacy, the use of LDN for chronic disorders is still highly experimental. Published trials have low sample sizes, and few replications have been performed.

One of the challenges in getting this treatment studied for treating pain is that it’s no longer under patent.

That means that Big Pharma can’t make a ton of money selling it.

It also means that Big Pharma companies are not likely to fund studies to see if the treatment is as good as some people are claiming.

However, because the dose is so small and the risk profile is relatively low…

…you may be able to get your doctor to give low-dose naltrexone off-label for you.

This is a legal practice, but you have to find a doctor that’s willing to do it.

“Randomized clinical trials should be performed to investigate whether LDN has a place in the treatment of rheumatic disease, either as an alternative or as an add-on to established pharmacotherapy. The expired patent on naltrexone makes commercial studies unlikely, but the low cost and LDNs outstanding safety profile make it an attractive candidate for both patients and those who pay for health services.”

Chronic pain can be extremely difficult to live with and to treat effectively.

I’m always interested in having another tool in the toolbox to use to help relieve chronic pain for people.

—-Important Message—-

How does an 84 year old man with extreme arthritis, a fractured knee, and a torn rotator cuff…humiliate young, expert golfers by hitting every tee shot out of sight straight down the fairway?

Can't see this image? Click on 'load images' or 'always allow images for this sender'

We’ve got an 84-year-old man here in town that can crush a golf ball like you’ve never seen.

What’s amazing is, not only is he 84… he’s also got a bad knee, a torn rotator cuff, and extreme arthritis!

And, guess what else?

He’s got several “golf buddies” who also hit the ball further and straighter than they should be able to.

You see, one guy is a 28 year old muscle-bound bodybuilder who can barely lift his hand over his shoulder.

Not only that, he’s got an ACL in his left knee.

ACL stands for “Anterior Cruciate Ligament.” It’s the ligament that connects your thigh bones to the skin-bone…

…and when it goes bad, it unravels like a braided rope.

It’s extremely painful.

Yet, this muscle-bound bodybuilder (with a little help from his 84 year old friend) can now drive a golf ball 377 yards straight as an arrow!

Here’s their secret (hint: it obliterates pain)

———-


Matt Cook is editor-in-chief of Daily Medical Discoveries. Matt has been a full time health researcher for 26 years. ABC News interviewed Matt on sexual health issues not long ago. Matt is widely quoted on over 1,000,000 websites. He has over 300,000 daily newsletter readers. Daily Medical Discoveries finds hidden, buried or ignored medical studies through the lens of 100 years of proven science. Matt heads up the editorial team of scientists and health researchers. Each discovery is based upon primary studies from peer reviewed science sources following the Daily Medical Discoveries 7 Step Process to ensure accuracy.
https://www.peoplespharmacy.com/articles/low-dose-naltrexone-ldn-provides-surprising-pain-reliefhttps://pubmed.ncbi.nlm.nih.gov/32845365/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962576/https://pubmed.ncbi.nlm.nih.gov/28325149/https://pubmed.ncbi.nlm.nih.gov/28510411/https://pubmed.ncbi.nlm.nih.gov/28607740/